₹1,837.9
-16 (-0.9%)![]()
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,875.42 | Bearish |
| 10-DMA | 1,890.2 | Bearish |
| 20-DMA | 1,813.89 | Bullish |
| 50-DMA | 1,811 | Bullish |
| 100-DMA | 1,822.93 | Bullish |
| 200-DMA | 1,877.04 | Bearish |
%
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Net Sales | 5,353 | 5,505 | 4,614 | 4,510 | 3,884 |
| Total Expenditure | 4,951 | 4,865 | 4,152 | 4,301 | 3,729 |
| Other Income | 27 | 55 | 62 | 134 | 89 |
| Operating Profit | 429 | 694 | 523 | 343 | 244 |
| Interest | 148 | 105 | 73 | 65 | 45 |
| Depreciation | 187 | 160 | 125 | 125 | 124 |
| Profit Before Tax | 81 | 429 | 302 | 153 | 74 |
| Consolidated Net Profit | 32 | 307 | 226 | 139 | 58 |
| Adjusted EPS | 6 | 58 | 42 | 26 | 11 |
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Share Capital | 53 | 53 | 13 | 13 | 13 |
| Total Reserves | 1,711 | 1,858 | 1,654 | 1,461 | 1,349 |
| Long-Term Borrowings | --- | --- | --- | --- | --- |
| Total Non-Current Liabilities | 1,043 | 564 | 382 | 390 | 469 |
| Other Current Liabilities | 381 | 342 | 318 | 289 | 235 |
| Short Term Borrowings | 1,096 | 964 | 795 | 543 | 632 |
| Total Liabilities | 4,645 | 4,197 | 3,486 | 2,901 | 2,991 |
| Capital Work in Progress | 58 | 273 | 10 | 110 | 1 |
| Long Term Loans & Advances | 109 | 86 | 79 | 96 | 44 |
| Currents Investments | 134 | 15 | 16 | 157 | 151 |
| Short Term Loans and Advances | 176 | 167 | 129 | 146 | 113 |
| Total Current Assets | 2,208 | 2,011 | 1,797 | 1,654 | 1,724 |
| Total Assets | 4,645 | 4,197 | 3,486 | 2,901 | 2,991 |
| Adjusted Book Value | 331 | 358 | 313 | 1,106 | 1,022 |
Investment Calculator
| Symbol | Change% |
|---|---|
| SUMICHEM | 502.3(14%) |
| ZENSARTECH | 516.1(10%) |
| AEGISVOPAK | 257.43(10%) |
| ECLERX | 1488.8(7%) |
| KAYNES | 3333.8(6%) |
Get Your Portfolio Reviewed

Stay Updated with Our Market Newsletters